Rahul Kakkar

Chief Executive Officer at

Pandion Operations, Inc.

51 year

Finance

Consumer Services

Profile

Rahul Kakkar was the founder of Corvidia Therapeutics, Inc., founded in 2015, where the title held was Chief Medical & Strategy Officer from 2018 to 2019.
Current jobs include Chief Executive Officer & Partner at Flagship Pioneering, Inc. starting in 2025; Chief Executive Officer & Director at Pandion Operations, Inc. starting in 2019; President, Chief Executive Officer & Director at Tome Biosciences, Inc.; President & Chief Executive Officer at Quotient Therapeutics Ltd. starting in 2025; and Independent Director at Attralus, Inc. starting in 2021.
Former jobs include Chief Executive Officer & Director at Pandion Therapeutics, Inc. from 2019 to 2021; Director-Emerging Innovations at AstraZeneca PLC from 2012 to 2016; and Entrepreneur-Partner at Polaris Growth Management LLC from 2021 to 2024.
Education includes undergraduate degree from Tufts University and doctorate from Tufts University School of Medicine.

Rahul Kakkar active positions

Companies	Position	Start
Pandion Operations, Inc. Pandion Operations, Inc. Develops drugs for autoimmune, inflammatory and transplant indications	Chief Executive Officer	2019-07-16
Attralus, Inc. Attralus, Inc. Develops novel pan-amyloid removal therapeutics	Director/Board Member	2021-05-09
Tome Biosciences, Inc. Tome Biosciences, Inc. Provides genomic medicine insertion and technologies services	Chief Executive Officer	-
Flagship Pioneering, Inc. Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor.	Private Equity Investor	2025-03-31

All active positions of Rahul Kakkar

Former positions of Rahul Kakkar

Companies	Position	End
Polaris Growth Management LLC Polaris Growth Management LLC Investment ManagersFinance Polaris Partners invests primarily in companies in the consumer technology, digital media/entertainment, e-Commerce, network hardware, software and semiconductors sectors. They invest in seed, early-stage and high growth, middle-market companies. The firm's early-stage investments focus on information technology and life sciences companies. Within the information technology sector, Polaris looks for companies that are developing Internet and broadband infrastructure, enterprise software products, e-Commerce products/services, digital media/entertainment, consumer software, network hardware and network software. In the life sciences sector, the firm looks for companies that are developing medical devices, pharmaceuticals, genomics, proteomics, drug delivery, medical services and consumer products and services. Polaris' private equity efforts focus on high-growth, middle-market companies in industries including technology, healthcare, digital media, consumer products and services and business services. Polaris serves as the lead or co-lead investor in the vast majority of their portfolio companies. The firm participates in minority growth equity investments, recapitalizations with liquidity and LBOs.	Private Equity Investor	2024-11-30
PANDION THERAPEUTICS, INC.	Chief Executive Officer	2021-03-31
Corvidia Therapeutics, Inc. Corvidia Therapeutics, Inc. Develops precision cardiovascular therapies	Founder	2019-04-30
ASTRAZENECA PLC	Corporate Officer/Principal	2015-12-31

See the detail of Rahul Kakkar's experience

Training of Rahul Kakkar

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rahul Kakkar's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
AstraZeneca PLC AstraZeneca PLC Manufactures pharmaceutical products
Polaris Growth Management LLC Polaris Growth Management LLC Investment ManagersFinance Polaris Partners invests primarily in companies in the consumer technology, digital media/entertainment, e-Commerce, network hardware, software and semiconductors sectors. They invest in seed, early-stage and high growth, middle-market companies. The firm's early-stage investments focus on information technology and life sciences companies. Within the information technology sector, Polaris looks for companies that are developing Internet and broadband infrastructure, enterprise software products, e-Commerce products/services, digital media/entertainment, consumer software, network hardware and network software. In the life sciences sector, the firm looks for companies that are developing medical devices, pharmaceuticals, genomics, proteomics, drug delivery, medical services and consumer products and services. Polaris' private equity efforts focus on high-growth, middle-market companies in industries including technology, healthcare, digital media, consumer products and services and business services. Polaris serves as the lead or co-lead investor in the vast majority of their portfolio companies. The firm participates in minority growth equity investments, recapitalizations with liquidity and LBOs.	Finance
Flagship Pioneering, Inc. Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor.	Finance
Tufts University Tufts University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Tufts University School of Medicine Tufts University School of Medicine Functions as a College/University
Corvidia Therapeutics, Inc. Corvidia Therapeutics, Inc. Develops precision cardiovascular therapies
Pandion Operations, Inc. Pandion Operations, Inc. Develops drugs for autoimmune, inflammatory and transplant indications
Pandion Therapeutics, Inc. Pandion Therapeutics, Inc. Operates as clinical stage biopharmaceutical company, which develops novel therapeutics for autoimmune diseases
Attralus, Inc. Attralus, Inc. Develops novel pan-amyloid removal therapeutics
Tome Biosciences, Inc. Tome Biosciences, Inc. Provides genomic medicine insertion and technologies services